Study of Adecatumumab Relative to FOLFOX After R0 Resection of Colorectal Liver Metastases

Summary

The purpose of this study is to determine the effect of adecatumumab alone or following FOLFOX in patients with R0 resected liver metastases from CRC (colorectal carcinoma) and to compare the effect to FOLFOX alone.

Timeline

Start

2009-03

Primary completion

2011-07

Completion

2011-11

Drugs

Indications